Concepts (150)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Models, Statistical | 1 | 2010 | 113 | 0.320 |
Why?
|
| Pituitary Apoplexy | 1 | 2005 | 1 | 0.240 |
Why?
|
| Pituitary Neoplasms | 1 | 2005 | 17 | 0.230 |
Why?
|
| Adenoma | 1 | 2005 | 61 | 0.220 |
Why?
|
| Neovascularization, Pathologic | 2 | 2015 | 35 | 0.190 |
Why?
|
| Cryosurgery | 2 | 2013 | 16 | 0.130 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 2016 | 8 | 0.130 |
Why?
|
| Monitoring, Intraoperative | 1 | 2016 | 36 | 0.120 |
Why?
|
| Scoliosis | 1 | 2016 | 33 | 0.120 |
Why?
|
| Pancreatic Neoplasms | 2 | 2015 | 88 | 0.120 |
Why?
|
| Phagocytosis | 1 | 2015 | 23 | 0.110 |
Why?
|
| Blood Platelets | 1 | 2015 | 35 | 0.110 |
Why?
|
| Endothelial Cells | 1 | 2015 | 59 | 0.110 |
Why?
|
| Dietary Proteins | 1 | 2014 | 26 | 0.110 |
Why?
|
| Muscles | 1 | 2014 | 56 | 0.100 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2013 | 4 | 0.100 |
Why?
|
| Combined Modality Therapy | 3 | 2013 | 295 | 0.100 |
Why?
|
| Dendritic Cells | 1 | 2013 | 34 | 0.100 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2013 | 25 | 0.100 |
Why?
|
| Humans | 13 | 2016 | 23169 | 0.100 |
Why?
|
| Iodine Radioisotopes | 1 | 2012 | 12 | 0.100 |
Why?
|
| Signal Transduction | 1 | 2015 | 399 | 0.100 |
Why?
|
| Brachytherapy | 1 | 2012 | 44 | 0.100 |
Why?
|
| Retinal Ganglion Cells | 1 | 2012 | 2 | 0.090 |
Why?
|
| Optic Disk | 1 | 2012 | 3 | 0.090 |
Why?
|
| Glaucoma | 1 | 2012 | 4 | 0.090 |
Why?
|
| Optic Nerve Diseases | 1 | 2012 | 4 | 0.090 |
Why?
|
| Tomography, Optical Coherence | 1 | 2012 | 13 | 0.090 |
Why?
|
| Nerve Fibers | 1 | 2012 | 11 | 0.090 |
Why?
|
| Liver Neoplasms | 1 | 2013 | 103 | 0.090 |
Why?
|
| Tyrosine-tRNA Ligase | 1 | 2011 | 2 | 0.090 |
Why?
|
| Furans | 1 | 2011 | 4 | 0.090 |
Why?
|
| Gram-Positive Bacteria | 1 | 2011 | 12 | 0.090 |
Why?
|
| Aged | 7 | 2014 | 7498 | 0.080 |
Why?
|
| Female | 9 | 2016 | 13059 | 0.080 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2010 | 2 | 0.080 |
Why?
|
| Male | 9 | 2016 | 12556 | 0.080 |
Why?
|
| Scleroderma, Systemic | 1 | 2010 | 7 | 0.080 |
Why?
|
| Adult | 6 | 2016 | 7031 | 0.080 |
Why?
|
| Algorithms | 1 | 2012 | 310 | 0.080 |
Why?
|
| Retrospective Studies | 4 | 2016 | 3026 | 0.080 |
Why?
|
| Spinal Fusion | 1 | 2016 | 430 | 0.080 |
Why?
|
| Double-Blind Method | 1 | 2010 | 382 | 0.080 |
Why?
|
| DNA Methylation | 1 | 2010 | 128 | 0.080 |
Why?
|
| Cerebral Arteries | 1 | 2009 | 21 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2009 | 3 | 0.080 |
Why?
|
| Middle Aged | 6 | 2014 | 8000 | 0.080 |
Why?
|
| ras Proteins | 1 | 2009 | 12 | 0.070 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2009 | 33 | 0.070 |
Why?
|
| ErbB Receptors | 1 | 2009 | 54 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 363 | 0.070 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2009 | 85 | 0.070 |
Why?
|
| Mutation | 1 | 2009 | 328 | 0.070 |
Why?
|
| Treatment Outcome | 3 | 2013 | 2971 | 0.060 |
Why?
|
| Adolescent | 2 | 2016 | 1916 | 0.060 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2009 | 236 | 0.060 |
Why?
|
| Hypophysectomy | 1 | 2005 | 3 | 0.060 |
Why?
|
| Neurofibrillary Tangles | 1 | 2006 | 119 | 0.060 |
Why?
|
| Hormone Replacement Therapy | 1 | 2005 | 32 | 0.060 |
Why?
|
| Substantia Nigra | 1 | 2006 | 101 | 0.060 |
Why?
|
| Coculture Techniques | 2 | 2015 | 29 | 0.050 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2006 | 119 | 0.050 |
Why?
|
| Lung Neoplasms | 1 | 2009 | 542 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2016 | 449 | 0.050 |
Why?
|
| Brain | 1 | 2009 | 1200 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2015 | 338 | 0.040 |
Why?
|
| Aged, 80 and over | 4 | 2012 | 3754 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2005 | 875 | 0.040 |
Why?
|
| Alzheimer Disease | 1 | 2009 | 1307 | 0.040 |
Why?
|
| Disease Progression | 2 | 2012 | 523 | 0.040 |
Why?
|
| Aging | 1 | 2006 | 1098 | 0.040 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2010 | 164 | 0.040 |
Why?
|
| Spinal Cord | 1 | 2016 | 74 | 0.030 |
Why?
|
| Umbilical Veins | 1 | 2015 | 3 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2015 | 21 | 0.030 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2015 | 11 | 0.030 |
Why?
|
| Cell Communication | 1 | 2015 | 23 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2015 | 53 | 0.030 |
Why?
|
| Cell Survival | 1 | 2015 | 98 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2015 | 131 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 57 | 0.030 |
Why?
|
| Malaysia | 1 | 2014 | 1 | 0.030 |
Why?
|
| India | 1 | 2014 | 16 | 0.030 |
Why?
|
| Apoptosis | 1 | 2015 | 196 | 0.030 |
Why?
|
| Anthropometry | 1 | 2014 | 28 | 0.030 |
Why?
|
| Nutrition Assessment | 1 | 2014 | 40 | 0.030 |
Why?
|
| China | 1 | 2014 | 45 | 0.030 |
Why?
|
| Arm | 1 | 2014 | 68 | 0.030 |
Why?
|
| Body Weight | 1 | 2014 | 129 | 0.030 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2014 | 37 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2013 | 41 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 1048 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 168 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2012 | 102 | 0.020 |
Why?
|
| Child | 1 | 2016 | 1171 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2012 | 59 | 0.020 |
Why?
|
| Cytokines | 1 | 2013 | 206 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2013 | 472 | 0.020 |
Why?
|
| ROC Curve | 1 | 2012 | 124 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2014 | 382 | 0.020 |
Why?
|
| Postoperative Period | 1 | 2012 | 242 | 0.020 |
Why?
|
| Palliative Care | 1 | 2012 | 107 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2011 | 34 | 0.020 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2011 | 55 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2011 | 79 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 2011 | 68 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2011 | 115 | 0.020 |
Why?
|
| Young Adult | 1 | 2016 | 1671 | 0.020 |
Why?
|
| Mice | 1 | 2015 | 1232 | 0.020 |
Why?
|
| Cyclin A1 | 1 | 2010 | 1 | 0.020 |
Why?
|
| Paired Box Transcription Factors | 1 | 2010 | 3 | 0.020 |
Why?
|
| Death-Associated Protein Kinases | 1 | 2010 | 4 | 0.020 |
Why?
|
| Sulfotransferases | 1 | 2010 | 4 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2010 | 10 | 0.020 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2010 | 15 | 0.020 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2010 | 33 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2010 | 41 | 0.020 |
Why?
|
| Time Factors | 1 | 2013 | 1275 | 0.020 |
Why?
|
| Staphylococcal Infections | 1 | 2011 | 155 | 0.020 |
Why?
|
| Logistic Models | 1 | 2010 | 357 | 0.020 |
Why?
|
| Gliosis | 1 | 2009 | 7 | 0.020 |
Why?
|
| Arterioles | 1 | 2009 | 11 | 0.020 |
Why?
|
| Encephalitis | 1 | 2009 | 10 | 0.020 |
Why?
|
| Microcirculation | 1 | 2009 | 25 | 0.020 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2009 | 15 | 0.020 |
Why?
|
| Cell Count | 1 | 2009 | 71 | 0.020 |
Why?
|
| Carcinoma, Adenosquamous | 1 | 2009 | 3 | 0.020 |
Why?
|
| Carcinoma, Large Cell | 1 | 2009 | 12 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 2009 | 24 | 0.020 |
Why?
|
| Gene Amplification | 1 | 2009 | 21 | 0.020 |
Why?
|
| Blood-Brain Barrier | 1 | 2009 | 34 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2009 | 19 | 0.020 |
Why?
|
| Base Sequence | 1 | 2009 | 100 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 115 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2009 | 187 | 0.020 |
Why?
|
| Brain Mapping | 1 | 2009 | 123 | 0.020 |
Why?
|
| Biopsy | 1 | 2009 | 192 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2009 | 210 | 0.020 |
Why?
|
| Microglia | 1 | 2009 | 109 | 0.020 |
Why?
|
| Amyloid beta-Peptides | 1 | 2009 | 197 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2009 | 135 | 0.020 |
Why?
|
| Survival Rate | 1 | 2009 | 323 | 0.020 |
Why?
|
| Animals | 1 | 2015 | 3272 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2009 | 359 | 0.020 |
Why?
|
| Biomarkers | 1 | 2009 | 476 | 0.020 |
Why?
|
| Prognosis | 1 | 2009 | 740 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2006 | 105 | 0.020 |
Why?
|
| Risk Factors | 1 | 2010 | 1988 | 0.010 |
Why?
|
| Dementia | 1 | 2006 | 388 | 0.010 |
Why?
|
| Parkinson Disease | 1 | 2006 | 586 | 0.010 |
Why?
|